Abstract
A mathematical model for Shiga 2 toxin neutralization by A-and B-subunit-specific human monoclonal antibodies initially delivered in the extracellular domain is presented, taking into account toxin and antibodies interaction in the extracellular domain, diffusion of toxin, antibodies, and their reaction products toward the cell, the receptor-mediated toxin and complex composed of toxin and antibody to A-subunit internalization from the extracellular into the intracellular medium and excretion of this complex back to the extracellular environment via recycling endosomal carriers. The retrograde transport of the intact toxin to the endoplasmic reticulum and its anterograde movement back to the vicinity of the plasma membrane with its subsequent exocytotic removal to the extracellular space via the secretory vesicle pathway is also taken into account. The model is composed of a set of coupled PDEs. A mathematical model based on a system of ODEs for Shiga 2 toxin neutralization by antibodies in the absence of cell is also studied. Both PDE and ODE systems are solved numerically. Numerical results are illustrated by figures and discussed.
Similar content being viewed by others
References
Jeong, K., Chapman-Bonofiglio, S., Singh, P., Lee, J., Tzipori, S.: In vitro and in vivo protective efficacies of antibodies that neutralize the RNA N-glycosidase activity of Shiga toxin 2. BMC Immunol. 11, 16 (2010)
Krautz-Peterson, G., Chapman-Bonofiglio, S., Boisvert, K., Feng, H., Herman, I.M., Tzipori, S.: Intracellular neutralization of Shiga toxin 2 by an A subunit-specific human monoclonal antibody. Infect. Immun. 76, 1931–1939 (2008)
Boerlin, P., McEwen, S.A., Boerlin-Petzold, F., Wilson, J.B., Johnson, R.P., Gyles, C.L.: Associations between virulence factors of Shiga toxin-producing Escherichia coli and disease in humans. J. Clin. Microbiol. 37, 497–503 (1999)
Griffin, P.M., Tauxe, R.V.: The epidemiology of infections caused by Escherichia coli O157:H7, other enterohemorrhagic E. coli, and the associated hemolytic uremic syndrome. Epidemiol. Rev. 13, 60–98 (1991)
Milford, D.V., Taylor, C.M., Guttridge, B., Hall, S.M., Rowe, B., Kleanthous, H.: Haemolytic uraemic syndromes in the British Isles 1985-8: association with verocytotoxin producing Escherichia coli. Part 1. Clinical and epidemiological aspects. Arch. Dis. Child 65, 716–721 (1990)
Ostroff, S.M., Tarr, P.I., Neill, M.A., Lewis, J.H., Hargrett-Bean, N., Kobayashi, J.M.: Toxin genotypes and plasmid profiles as determinants of systemic sequelae in Escherichia coli 0197-H7 infections. J. Infect. Dis. 160, 994–998 (1989)
Lingwood, C.A., Law, H., Richardson, S., Petric, M., Brunton, J.L., De Grandis, S., Karmali, M.: Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro. J. Biol. Chem. 262, 8834–8839 (1987)
Waddell, T., Head, S., Petric, M., Cohen, A., Lingwood, C.: Globotriosyl ceramide is specifically recognized by the Escherichia coli verocytotoxin 2. Biochem. Biophys. Res. Commun. 152, 674–679 (1988)
Sandvig, K., Van Deurs, B.: Endocytosis, intracellular transport, and cytotoxic action of Shiga toxin and ricin. Physiol. Rev. 76, 949–966 (1996)
Garred, O., Dubinina, E., Holm, P.K., Olsnes, S., van Deurs, B., Kozlov, J.V., Sandvig, K.: Role of processing and intracellular transport for optimal toxicity of Shiga toxin and toxin mutants. Exp. Cell Res. 218, 39–49 (1995)
Endo, Y., Tsurugi, K., Yutsudo, T., Takeda, Y., Ogasawara, T., Igarashi, K.: Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins. Eur. J. Biochem. 171, 45–50 (1988)
Saxena, S.K., O’Brien, A.D., Ackerman, E.J.: Shiga toxin, Shiga-like toxin II variant, and ricin are all single-site RNA N-glycosidases of 28 S RNA when microinjected into Xenopus oocytes. J. Biol. Chem. 264, 596–601 (1989)
Mukherjee, J., Chios, K., Fishwild, D., Hudson, D., O’Donnell, S., Rich, S.M., Donohue-Rolfe, A., Tzipori, S.: Human Stx2-specific monoclonal antibodies prevent systemic complications of Escherichia coli O157:H7 infection. Infect. Immun. 70, 612–619 (2002)
Sheoran, A.S., Chapman-Bonofiglio, B.R., Harvey, B.R., Mukherjee, J., Georgiou, G., Donohue-Rolfe, A., Tzipori, S.: Human antibody against Shiga toxin 2 administered to piglets after the onset of diarrhea due to Escherichia coli O157:H7 prevents fatal systemic complications. Infect. Immun. 73, 4607–4613 (2005)
Tzipori, S., Sheoran, A., Akiyoshi, D., Donohue-Rolfe, A., Trachtman, H.: Antibody therapy in the management of Shiga toxin-induced hemolytic uremic syndrome. Clin. Microbiol. Rev. 17, 926–941 (2004)
Sandvig, K., van Deurs, B.: Transport of protein toxins into cells: pathways used by ricin, cholera toxin, and Shiga toxin. FEBS Lett. 529, 49–53 (2002)
Skakauskas, V., Katauskis, P.: Modelling of toxin-antibody interaction and toxin transport toward the endoplasmic reticulum. J. Biol. Phys. 42, 83–97 (2016)
Smith, D.A., Simmons, R.M.: Models of motor-assisted transport of intracellular particles. Biophys. J. 80, 45–68 (2001)
Friedman, A., Cracium, G.: A model of intracellular transport of particles in an axon. J. Math. Biol. 51, 217–246 (2005)
Grant, B.D., Donaldson, J.G.: Pathways and mechanisms of endocytic recycling. Nat. Rev. Mol. Cell Biol. 10, 597–608 (2009)
Vale, R.D., Reese, T.S., Sheetz, M.P.: Identification of a novel force-generating protein, kinesin, involved in microtubule-based motility. Cell 42, 39–50 (1985)
Vale, R.D., Schnapp, B.J., Reese, T.S., Sheetz, M.P.: Movement of organelles along filaments dissociated from the axoplasm of the squid giant axon. Cell 40, 449–454 (1985)
Alberts, B., Bray, D., Lewis, J., Raff, M., Roberts, K., Watson, J.D.: : Molecular Biology of the Cell, 3rd edn. Garland Publishing, New York (1994)
Wang, S., Hsu, S.C.: The molecular mechanisms of the mammalian exocyst complex in exocytosis. Biochem. Soc. Trans. 34, 687–690 (2006)
Press, W.H., Teukolsky, S.A., Vetterling, W.T., Flannery, B.P.: : Numerical Recipes: The Art of Scientific Computing, 3rd edn. Cambridge University Press, Cambridge, UK (2007)
Shampine, L.F., Gladwell, I., Thompson, S., Beardah, C.: Solving ODEs with MATLAB. Cambridge University Press, Cambridge, UK (2003)
Samarskii, A.A.: The Theory of Difference Schemes. Marcel Dekker, New York (2001)
Truskey, G.A., Yuan, F., Katz, D.F.: Transport Phenomena in Biological Systems, 2nd edn. Pearson Prentice Hall Bioengineering (2009)
Lord, J.M., Spooner, R.A.: Ricin trafficking in plant and mammalian cells. Toxins 3, 787–801 (2011)
Van Deurs, B., Sandvig, K., Peterson, O.W., Olsnes, S., Simons, K., Griffiths, G.: Estimation of the amount of internalized ricin that reaches the trans-Golgi network. J. Cell Biol. 106, 253–267 (1988)
Nakajima, H., Kiyokawa, N., Katagiri, Y.U., Taguchi, T., Suzuki, T., Sekino, T., Mimori, K., Ebata, T., Saito, M., Nakao, H., Takeda, T., Fujimoto, J.: Kinetic analysis of binding between Shiga toxin and receptor glycolipid Gb3Cer by surface plasmon resonance. J. Biol. Chem. 276, 42915–42921 (2001)
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing Interests
The authors declare that they have no competing interests.
Rights and permissions
About this article
Cite this article
Skakauskas, V., Katauskis, P. Modeling neutralization of Shiga 2 toxin by A-and B-subunit-specific human monoclonal antibodies. J Biol Phys 42, 435–452 (2016). https://doi.org/10.1007/s10867-016-9416-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10867-016-9416-5